Richard Schilsky to Biliary Tract Neoplasms
This is a "connection" page, showing publications Richard Schilsky has written about Biliary Tract Neoplasms.
Connection Strength
0.833
-
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. J Clin Oncol. 2024 Sep 20; 42(27):3228-3237.
Score: 0.833